KIFC1 was identified as a component gene in an expression signature predictive of NSCLC metastasis to the brain [194], and its expression was elevated in the serum of lung cancer patients compared to healthy individuals [190], indicating its potential utility as a prognostic biomarker. This evidence concerns the gene KIFC1 and lung cancer.